DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 070098
The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.
Summary for 070098
Tradename: | METHYLDOPA |
Applicant: | Ivax Sub Teva Pharms |
Ingredient: | methyldopa |
Patents: | 0 |
Therapeutic Class: | Cardiovascular Agents |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 070098
Mechanism of Action | Adrenergic alpha2-Agonists |
Medical Subject Heading (MeSH) Categories for 070098
Suppliers and Packaging for NDA: 070098
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHYLDOPA | methyldopa | TABLET;ORAL | 070098 | ANDA | Teva Pharmaceuticals USA Inc | 0093-2931 | N | 0093-2931-01 |
METHYLDOPA | methyldopa | TABLET;ORAL | 070098 | ANDA | Teva Pharmaceuticals USA Inc | 0093-2931 | N | 0093-2931-10 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Feb 20, 1986 | TE: | AB | RLD: | No |
Complete Access Available with Subscription